Solutions Market growth is driven by rising hospitalization rates, increasing prevalence of chronic diseases, expanding surgical volumes, and growing demand for parenteral nutrition and fluid ...

Baxter International Inc. (NYSE:BAX) is one of the top cheap stocks under $20 to buy now. On December 12, Wells Fargo analyst ...

Learn more about whether AtriCure, Inc. or Baxter International Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...

Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...

Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. Driven by optimism about AI and a ...

Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on ...

Baxter International shares fell sharply this morning as third quarter results missed expectations and the medtech company lowered its 2025 outlook. The Deerfield-based company also announced it would ...

Hurricane Helene left a trail of devastation and destruction last year, dumping 40 trillion gallons of water on the Southeast. It leveled houses, sent trees crashing and left millions without power.

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems ...